ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "gender"

  • Abstract Number: 1225 • ACR Convergence 2022

    Sphygmomanometry for Fibromyalgia Detection in a Rheumatology Outpatient Clinic. a Cross-sectional Study

    Viridiana Del Río Guerrero1, Laura Aline Martínez Martínez1, Karina Arias Callejas1, Natalia Carbonell-Bobadilla2, Alejandra Mejía Segura1, Gibrán Azamar Morales1, Alejandra Espinosa Orantes1, Mauricio Mora Ramírez1, Fernanda Mejía Ávila1, Raúl Molina Sánchez1, Angélica Vargas-Guerrero1, Luis H Silveira1 and Manuel Martínez-Lavín3, 1Instituto Nacional de Cardiología, Ciudad de México, Mexico, 2National Institute of Cardiology Ignacio Chávez, Ciudad de México, Mexico, 3Instituto Nacional de Cardiología Ignacio Chávez, Ciudad de México, Mexico

    Background/Purpose: Allodynia is a key fibromyalgia (FM) feature. Women suffering from FM display more often sphygmomanometry-elicited allodynia when compared to women with osteoarthritis, rheumatoid arthritis…
  • Abstract Number: 0096 • ACR Convergence 2022

    Delayed Referral of Female Rheumatoid Arthritis Patients: Where Are We Now? A Study Spanning Three Decades

    Bastiaan van Dijk1 and Annette van der Helm-van Mil2, 1Leiden University Medical Centre (LUMC), Leiden, Netherlands, 2Leiden University Medical Center, Erasmus Medical Center, Leiden, Netherlands

    Background/Purpose: Delayed referral of female RA-patients was reported twenty years ago: the time between the first appointment with the general practitioner (GP) and referral to…
  • Abstract Number: 1497 • ACR Convergence 2022

    How Does Time to Diagnosis and Gender Affect Treatment Outcomes in Patients with Ankylosing Spondylitis or Psoriatic Arthritis? – Real World Data from a German Observational Study with Secukinumab

    Karolina Benesova1, Oliver Hansen2, Uta Kiltz3, Jan Brandt-Juergens4, Peter Kästner5, Elke Riechers6, Daniel Peterlik7, Christina Budden7, Annika Boas7, Stefanie Welle7 and Hans-Peter Tony8, 1University Hospital Heidelberg, Heidelberg, Germany, 2Medizinische Abteilung V - Rheumatologie, Universitätsklinikum, Heidelberg, Germany, 3Rheumazentrum Ruhrgebiet, Herne, Germany, 4Rheumatologische Schwerpunktpraxis, Berlin, Germany, 5Ambulantes Rheumazentrum, Medizinisches Versorgungszentrum, Erfurt, Germany, 6Medizinische Hochschule Hannover, Hannover, Germany, 7Novartis Pharma GmbH, Nürnberg, Germany, 8Medizinische Klinik II - Rheumatologie/Immunologie, Universitätsklinikum Würzburg, Würzburg, Germany

    Background/Purpose: In both, ankylosing spondylitis (AS) and psoriatic arthritis (PsA), women typically have a longer delay in diagnosis.1,2 There is scientific evidence that prognosis for…
  • Abstract Number: 0097 • ACR Convergence 2022

    Sex and Race/ethnicity Differences in Knee Symptoms, Function, and Radiographic Features: Preliminary Descriptive Data from the Johnston County Health Study

    Luis Palomino1, Carolina Alvarez2, Todd Schwartz3, Yvonne Golightly4 and Amanda Nelson2, 1University of North Carolina Chapel hill, Chapel Hill, NC, 2University of North Carolina at Chapel Hill, Chapel Hill, NC, 3University of North Carolina-Chapel Hill, Chapel Hill, NC, 4University of Nebraska Medical Center, Omaha, NE

    Background/Purpose: Osteoarthritis (OA) is the most common form of joint disorder worldwide. Differences in pain, function, and radiographic features in ethnic groups, specifically Hispanics, are…
  • Abstract Number: 1601 • ACR Convergence 2022

    Female Psoriatic Arthritis Patients Show Differences in Treatment Response to IL12/23 Inhibition in Combination with or Without MTX Compared to Male – Results from a Multicenter Investigator-initiated Randomized Placebo-controlled Clinical Trial

    Michaela Koehm1, Ann Christina Foldenauer2, Tanja Rossmanith3, Herbert Kellner4, Uta Kiltz5, Juergen Rech6, Gerd Burmester7, David Kofler8, Jan Brandt-Juergens9, Stephanie Finzel10, Raoul Bergner11, Maren Sieburg12 and Frank Behrens13, 1Rheumatology Goethe-University Frankfurt, Frankfurt Am Main, Germany, 2Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Frankfurt, 3Fraunhofer Institute for Translational Medicine & Pharmacology ITMP, Frankfurt, Germany, 4Schwerpunktpraxis für Rheumatologie und Gastroenterologie, Munich, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany, 6University Clinic Erlangen, Erlangen, Germany, 7Charité University Medicine Berlin, Berlin, Germany, 8University of Cologne, Cologne, Germany, 9Rheumatologische Schwerpunktpraxis, Berlin, Germany, 10University of Freiburg, Freiburg, Germany, 11Klinikum Ludwigshafen, Ludwigshafen, Germany, 12Rheumatologische Facharztpraxis, Magdeburg, Germany, 13Rheumatology University Hospital & Fraunhofer Institute Translational Medicine and Pharmacology, Goethe-University Frankfurt, Frankfurt Am Main, Germany

    Background/Purpose: Subgroup analysis from different clinical trials and real-world data suggest, that there are differences in baseline characteristics, clinical phenotypes, and treatment responses in female…
  • Abstract Number: 0111 • ACR Convergence 2022

    Gender Equity in the Asia Pacific: Comparison of Indian and Philippines Rheumatology Conferences

    Lisa S Traboco1, Geraldine Zamora2, Kavitha Mohanasundaram3, Sheila Marie Reyes4, Annamalai Sowndhariya5, Pavel Ovseiko6, vinod Ravindran7 and Latika Gupta8, 1St Luke's Medical Center - BGC, Manila, Philippines, 2Philippine Rheumatology Association, Taguig City, Philippines, 3Saveetha Medical College Hospital, Chennai, India, 4St. Luke's Medical Center, Cainta, Philippines, 5MIOT Hospital, Chennai, India, 6John Radcliffe Hospital, Oxford, Oxford, United Kingdom, 7Centre for Rheumatology, Kozhikode, Kozhikode, India, 8Royal Wolverhampton Trust, Wolverhampton/University of Manchester, United Kingdom

    Background/Purpose: Equitable gender representation at conferences is essential to further progress in academia. India and the Philippines are both low and middle-income countries in the…
  • Abstract Number: 1672 • ACR Convergence 2022

    The Impact of Systemic Sclerosis (SSc) on Women’s Health Evaluated with a New SSc-specific Patient-reported Questionnaire

    Maria Grazia Lazzaroni1, Liala Moschetti1, Eleonora Pedretti1, Andrea Lojacono2, Francesca Ramazzotto3, Cristina Zanardini3, Zatti Sonia3, Angela Tincani4, Franco Franceschini1, Paolo Airò5 and Laura Andreoli1, 1Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Brescia, Italy, 2Obstetrics and Gynecology, ASST Garda, Desenzano del Garda, Brescia, Brescia, Italy, 3Obstetrics and Gynecology, ASST Spedali Civili and University of Brescia, Brescia, Italy, 4Rheumatology and Clinical Immunology Unit, ASST Spedali Civili and University of Brescia, Gussago, Italy, 5Rheumatology and Clinical Immunology Unit, ASST Spedali Civili, Brescia, Italy

    Background/Purpose: Systemic Sclerosis (SSc) has a strong female predominance and can significantly impair the everyday quality of life of patients. We aimed at designing a…
  • Abstract Number: 0227 • ACR Convergence 2022

    The Rheumatology Workforce: Analyzing Geographic and Temporal Variations Among the Rheumatology Physician Workforce in the United States

    Kavish Singh1, Lynn Foster-Johnson2, Sladjana Skopelja-Gardner3, Arabi Rasendrakumar4, Temitope Ajayi5 and Aakanksha Khanna6, 1Montefiore Medical Center, Brooklyn, NY, 2Dartmouth Geisel School of Medicine, Lebanon, NH, 3Dartmouth Hitchcock Medical Center, Lebanon, NH, 4University of Buffalo, Buffalo, NY, 5University at Buffalo, Buffalo, NY, 6Dartmouth-Hitchcock Medical Center, Lebanon, NH

    Background/Purpose: To analyze recent trends in the rheumatology workforce related to temporal and national geographic variation in the United States (US). Methods: The publicly available physician workforce…
  • Abstract Number: 1725 • ACR Convergence 2022

    Sex Differences in Autoimmune Pathogenesis and Systemic Response to High Fat Diet in Lupus-prone Mice

    Gitanjali Lobo1, Juan Meng2, Xuhua Shi2, Ronak Patel3, Laura Rivers4, Chad Hille5, Robert Quinet6, William Davis7, Jerald Zakem8, Chandana Keshavamurthy9, Tamika Webb-Detiege10, Zongbing You2 and Xin Zhang11, 1Ochsner Clinic Foundation, Metairie, LA, 2Tulane University, New Orleans, LA, 3Ochsner, New Orleans, LA, 4Ochsner Medical Center, River Ridge, LA, 5Ochsner Clinic Foundation, New Orleans, LA, 6Ochsner Health, River Ridge, LA, 7Ochsner Medical Center, New Orleans, LA, 8Ochsner Health Systems, Metairie, LA, 9ochsner medical center, Metairie, LA, 10University of Queensland/Ochsner Clinical School, New Orleans, LA, 11Institution of Translational Research, Ochsner Health System, New Orleans, LA

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by chronic inflammation and the production of autoantibodies, leading to systemic multiorgan damage. SLE has…
  • Abstract Number: 0241 • ACR Convergence 2022

    Inequity in Disease Impact Between Male and Female Rheumatoid Arthritis Patients

    Gonul Hazal Koc1 and Pascal de Jong2, 1Department of Rheumatology, Erasmus University Medical Centre, Rotterdam, the Netherlands, Rotterdam, Netherlands, 2ErasmusMC, Hendrik Ido Ambacht, Netherlands

    Background/Purpose: Rheumatoid arthritis (RA) is more common in females than males. Moreover, males and females may have different disease courses and burdens, but data on…
  • Abstract Number: 1768 • ACR Convergence 2022

    Sex-Related Differences in Healthcare Utilization in Patients with Inflammatory Arthritis: A Population-based Study

    Sanjana Tarannum1, Jessica Widdifield1, C. Fangyun Wang2, Sindhu R. Johnson3, Paula Rochon1 and Lihi Eder4, 1University of Toronto, Toronto, ON, Canada, 2Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, 3Division of Rheumatology, Department of Medicine, Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western and Mount Sinai Hospitals; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON, Canada, 4Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada

    Background/Purpose: Delayed diagnosis of inflammatory arthritis (IA), including rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA), is associated with joint damage and disability.…
  • Abstract Number: 0381 • ACR Convergence 2022

    Most Disease Outcome Measures but Not ASDAS Are Influenced by Gender in Patients with Axial SpA: Results from ASAS-PerSpA

    Diego Benavent1, Dafne Capelusnik2, Sofia Ramiro3, Anna Molto4, Clementina Lopez-Medina5, Maxime Dougados6 and Victoria Navarro-Compán7, 1La Paz University Hospital, Madrid, Spain, 2Instituto de Rehabilitación Psicofísica (IREP), Buenos Aires, Argentina, 3Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology Department, Hôpital Cochin,Assistance Publique- Hôpitaux de Paris, Paris, France, 5Reina Sofia University Hospital, Rheumatology Department, Jaén, Spain, 6Department of Rheumatology, Hôpital Cochin, Paris, France, Paris, France, 7Department of Rheumatology, La Paz University Hospital, IdiPaz, Madrid, Spain

    Background/Purpose: There is growing evidence revealing that females report worse patient-reported outcomes compared to males in axial spondyloarthritis (axSpA). However, in which precise outcomes there…
  • Abstract Number: 2137 • ACR Convergence 2022

    Impact of Patient Characteristics, Including Sex, on the Efficacy of Upadacitinib Compared with Adalimumab in Patients with Psoriatic Arthritis

    Lihi Eder1, Laura Coates2, Peter Nash3, Uta Kiltz4, Ennio Lubrano5, Erin McDearmon-Blondell6, Tianming Gao7 and Alexis Ogdie8, 1Women’s College Research Institute, Department of Medicine, University of Toronto, Toronto, ON, Canada, 2Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK, Oxford, England, United Kingdom, 3School of Medicine, Griffith University, Brisbane, Australia, 4Rheumazentrum Ruhrgebiet, Herne, Germany, 5Academic Rheumatology Unit, Dipartimento di Medicina e Scienze della Salute ‘‘Vincenzo Tiberio’’, Università degli Studi del Molise, Campobasso, Italy, 6AbbVie, Inc., Mettawa, IL, 7AbbVie, Inc., North Chicago, IL, 8Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA

    Background/Purpose: Evidence suggests that response to treatment in PsA may vary with patient (pt) characteristics, such as sex.1 This post hoc analysis of the Phase…
  • Abstract Number: 0849 • ACR Convergence 2022

    The Impact of Diabetes Status on Pain and Disability Following Total Joint Arthroplasty for Hip and Knee Osteoarthritis: Variation by Sex and Body Mass Index

    J Denise Power1, Anthony Perruccio2, J Roderick Davey2, Rajiv Gandhi2, Nizar Mahomed2, Khalid Syed2, Christian Veillette2 and Y Raja Rampersaud2, 1Schroeder Arthritis Institute, University Health Network, Toronto, ON, Canada, 2Schroeder Arthritis Institute, University Health Network; University of Toronto, Toronto, ON, Canada

    Background/Purpose: Hip and knee total joint arthroplasties (TJA) for osteoarthritis (OA) are frequently performed surgical procedures, representing the majority of direct expenditures for OA. TJA…
  • Abstract Number: 2152 • ACR Convergence 2022

    Depression and Other Neurological Disorders Are Associated with Biologic DMARD Failure in Psoriatic Arthritis

    Nicoletta Luciano1, Elisa Barone2, Enrico Brunetta1, Maria De Santis3, Angela Ceribelli4, Marta Caprioli5, Giacomo Maria Guidelli1, Arianna Sonaglia1, Daniela Renna6, Francesca Motta7, Natasa Isailovic7, Matteo Vecellio3 and Carlo Selmi8, 1IRCCS Humanitas Research Hospital, Rheumatology and Clinical Immunology, Rozzano, Italy, 2IRCCS Humanitas Research Hospital, Rheumatology and Clinical Immunology, Rozzano (MI), Lombardia, Italy, 3Humanitas University, IRCCS Humanitas Research Hospital, Rheumatology and Clinical Immunology, Pieve Emanuele, Italy, 4Humanitas Research Hospital, Humanitas University, Rozzano (MI) Italy, Borgo San Giacomo, Italy, 5IRCCS Humanitas Research Hospital, Rheumatology and Clinical Immunology, Pavia, Italy, 6IRCCS Humanitas Research Hospital, Rheumatology and Clinical Immunology, Milano, Italy, 7Humanitas University, IRCCS Humanitas Research Hospital, Rheumatology and Clinical Immunology, Rozzano (MI), Italy, 8Humanitas University, IRCCS Humanitas Research Hospital, Rheumatology and Clinical Immunology, Rozzano, Italy

    Background/Purpose: The management of patients with psoriasis and psoriatic artrhitis (PsA) has been recently enriched and has thus become more challenging by the wide armamentarium…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology